We found the genotype distribution of that the PPARG rs3856806 C>T polymorphism was still significantly different between CRC patients and controls (TT/CT vs. CC: adjusted OR, 1.26; 95% CI 95% CI 1.06–1.49; P = 0.009). This evidence concerns the gene PPARG and colorectal carcinoma.